We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

72 hedge funds and large institutions have $273M invested in Albireo Pharma Inc in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

40% more capital invested

Capital invested by funds: $195M → $273M (+$78.2M)

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

6% more funds holding

Funds holding: 68 → 72 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

53% less call options, than puts

Call options by funds: $193K | Put options by funds: $412K

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
26
Reduced
20
Closed
1
Calls
$193K
Puts
$412K
Net Calls
-$219K
Net Calls Change
-$170K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.57M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$3.59M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$1.3M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.17M
5
MWNA
Marshall Wace North America
New York
+$682K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.64M
2
Renaissance Technologies
Renaissance Technologies
New York
-$358K
3
Morgan Stanley
Morgan Stanley
New York
-$332K
4
BlackRock
BlackRock
New York
-$304K
5
Victory Capital Management
Victory Capital Management
Texas
-$236K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$54.9M – – –
Federated Hermes
2
Federated Hermes
Pennsylvania
$23.2M +$3.59M +133,449 +23%
TGHSA
3
TPG Group Holdings (SBS) Advisors
Texas
$23.1M – – –
ACH
4
ArrowMark Colorado Holdings
Colorado
$21.3M +$1.3M +48,450 +8%
BlackRock
5
BlackRock
New York
$18.5M -$304K -11,309 -2%
AG
6
Artal Group
Luxembourg
$16.1M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$13.5M -$1.64M -60,900 -13%
PM
8
Prosight Management
Texas
$8.69M -$8.35K -310 -0.1%
BBA
9
Baker Bros. Advisors
New York
$8.05M – – –
SAM
10
Sectoral Asset Management
Quebec, Canada
$7.83M +$350K +13,000 +6%
BI
11
BVF Inc
California
$6.46M – – –
FI
12
Fosun International
China
$6.27M – – –
CC
13
Chicago Capital
Illinois
$6.1M +$229K +8,497 +5%
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$5.91M +$4.57M +169,795 +1,239%
Vanguard Group
15
Vanguard Group
Pennsylvania
$5.2M +$113K +4,179 +3%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$5.14M +$1.17M +43,467 +37%
HA
17
Heartland Advisors
Wisconsin
$4.83M +$673K +25,000 +20%
State Street
18
State Street
Massachusetts
$4.58M +$79.2K +2,941 +2%
TCM
19
Tekla Capital Management
Massachusetts
$4.03M – – –
Northern Trust
20
Northern Trust
Illinois
$3.78M +$96.1K +3,569 +3%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.5M +$304K +11,282 +12%
Victory Capital Management
22
Victory Capital Management
Texas
$2.04M -$236K -8,780 -12%
WMSA
23
Weiss Multi-Strategy Advisers
New York
$1.93M – – –
BC
24
Birchview Capital
Vermont
$1.22M – – –
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.22M +$9.05K +336 +0.9%
1
2 3

ALBO Hedge Fund Activity: Q1 2019 in Review

72 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2019, worth a combined $273M — up 40% from $195M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALBO positions and 1 closed out — a net gain of 4 holders — while 26 added to existing stakes and 20 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $4.57M. The largest seller was Fidelity Investments, cutting an estimated $1.64M.

  • 72 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2019, up from 68 in Q4 2018.
  • Funds reported $273M of Albireo Pharma Inc stock for Q1 2019, up 40% quarter-over-quarter.
  • 5 funds opened new Albireo Pharma Inc positions in Q1 2019 and 1 closed out, a net change of +4 holders.
  • The largest Albireo Pharma Inc buyer in Q1 2019 was Point72 Asset Management, an estimated $4.57M added.
  • The largest Albireo Pharma Inc seller in Q1 2019 was Fidelity Investments, an estimated $1.64M sold.

Based on aggregated 13F filings for Q1 2019.